Mechanisms of bone loss in inflammatory arthritis: Diagnosis and therapeutic implications

Arthritis Research

Volumn 2, Issue 1, 2000, Pages 33-37

  Goldring, S R ^a   Gravallese, E M ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Bone loss; Cytokines; Osteoclast; Osteoporosis; Rheumatoid arthritis

Indexed keywords

BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CORTICOSTEROID; ESTROGEN; PARATHYROID HORMONE;

ARTHRITIS; BONE ATROPHY; BONE DISEASE; BONE REMODELING; BONE TISSUE; DISEASE MODEL; HISTOPATHOLOGY; HUMAN; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PATHOLOGY; REVIEW; RHEUMATOID ARTHRITIS; SERUM; SKELETON; URINE;

ARTHRITIS, RHEUMATOID; BONE DENSITY; FEMALE; HUMANS; JOINTS; MALE; OSTEOPOROSIS;

EID: 0034469421     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar67     Document Type: Review

References (56)

1. Bone mass measurement and bone metabolism in rheumatoid arthritis: A review
2. Osteoporosis and rheumatic diseases
3. Bone disease in rheumatological disorders
4. Dynamics of bone remodeling
5. Osteonal and hemiosteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone
6. Modulation of osteoclast differentiation
7. Chondroclasts and osteoclasts at subchondral sites of erosions in the rheumatoid joint
8. Histopathology of the rheumatoid lesion; identification of cell types at sites of cartilage erosion
9. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
10. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
11. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis
12. Osteoclast-like cells in murine collagen-induced arthritis
13. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritis rats with accompanying disordered high bone turnover
14. Localization of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory and degenrative arthritis
15. Bone resorption by cells isolated from rheumatoid synovium
16. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis
17. Localization of tumour necrosis factor-α in synovial tissue and at the cartilage-pannus junction in patients with rheumatoid arthritis
18. Detection of cytokines at the cartilage/ pannus junction in patients with rheumatoid arthritis; implications for the role of cytokines in cartilage destruction and repair
19. Localization of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis
20. Cytokines in the pathogenesis of osteoporosis
21. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of oteoclastogenesis
22. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
23. Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the arthritis
24. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
25. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells
26. Activated T lymphocytes support osteoclast formation
27. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
28. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
29. Increased bone mass with Pamidronate treatment in rheumatoid arthritis
30. Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis
31. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis
32. Adjuvent oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis
33. Postmenopausal bone loss in rheumatoid arthritis: Effects of estrogens and androgens
34. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis
35. Effects of hormone replacement therapy in rheumatoid arthritis: A double blind placebo-controlled study
36. Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis
37. NE-58095: A diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis
38. Quantitative histological studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis
39. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis
40. Generalized bone loss in patients with rheumatoid arthritis
41. Risk of vertebral fracture in women with rheumatoid arthritis
42. Fractures after rheumatoid arthritis; a population based study
43. Predictors of fractures in early rheumatoid arthritis
44. Vertebral osteoporosis in rheumatoid arthritis
45. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?
46. Bone loss in rheumatoid arthritis: What role does inflammation play
47. Bone mass in patients with rheumatoid arthritis
48. Bone turnover in early rheumatoid arthritis; longitudinal bone density studies
49. Determinants of axial bone loss in rheumatoid arthritis
50. Bone remodeling in osteoporosis associated with rheumatoid arthritis
51. Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis
52. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis
53. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease
54. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritis disease
55. Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis
56. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial